Siddhika Salke

Possess a Distinction-awarded B.Tech degree in Biotechnology with extensive skills in bioinformatics, molecular modelling and drug designing along with a project experience in Quality Control Analysis of Pharmaceutical Ingredients, positioned for success in impactful biotechnology roles. Pursued an MSc in Pharmaceutical Analysis, Technology and Biopharmaceuticals at King's College London, coursework and a research project in Directed Evolution for Drug Synthesis equipped with the skills and knowledge for impactful contributions to the bioinformatics and biopharmaceutical sectors. Biotechnologist proficient in C++, Perl and Bio Perl, merging computational skills with expertise in Molecular Modeling, Drug Designing, R programming and Structural Biology. Specialized in automating processes, analyzing biological data and contributing to innovative solutions in biotechnology.

Possess a Distinction-awarded B.Tech degree in Biotechnology with extensive skills in bioinformatics, molecular modelling and drug designing along with a project experience in Quality Control Analysis of Pharmaceutical Ingredients, positioned for success in impactful biotechnology roles. Pursued an MSc in Pharmaceutical Analysis, Technology and Biopharmaceuticals at King's College London, coursework and a research project in Directed Evolution for Drug Synthesis equipped with the skills and knowledge for impactful contributions to the bioinformatics and biopharmaceutical sectors. Biotechnologist proficient in C++, Perl and Bio Perl, merging computational skills with expertise in Molecular Modeling, Drug Designing, R programming and Structural Biology. Specialized in automating processes, analyzing biological data and contributing to innovative solutions in biotechnology.

Pursued an MSc in Pharmaceutical Analysis, Technology and Biopharmaceuticals at King's College London, coursework and a research project in Directed Evolution for Drug Synthesis equipped with the skills and knowledge for impactful contributions to the bioinformatics and biopharmaceutical sectors.